GoodRx Holdings GDRX reported its Q1 earnings results on Wednesday, May 10, 2023 at 06:02 AM.
Here's what investors need to know about the announcement.
Earnings
GoodRx Holdings beat estimated earnings by 16.67%, reporting an EPS of $0.07 versus an estimate of $0.06.
Revenue was down $19.34 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 3.97% increase in the share price the next day.
Here's a look at GoodRx Holdings's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.05 | 0.04 | 0.04 | 0.08 |
| EPS Actual | 0.07 | 0.07 | 0.06 | 0.10 |
| Revenue Estimate | 178.50M | 185.33M | 184.71M | 200.44M |
| Revenue Actual | 184.11M | 187.32M | 191.80M | 203.33M |
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.05 | 0.04 | 0.04 | 0.08 |
| EPS Actual | 0.07 | 0.07 | 0.06 | 0.10 |
| Revenue Estimate | 178.50M | 185.33M | 184.71M | 200.44M |
| Revenue Actual | 184.11M | 187.32M | 191.80M | 203.33M |
To track all earnings releases for GoodRx Holdings visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.